This article was adapted from STAT’s latest report, “Subgroup analysis: how to evaluate post hoc tests for significance in failed clinical trials.” Clinical trials of newly developed drugs often don’t ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback